Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

19.74
Delayed Data
As of Feb 12
 +0.21 / +1.08%
Today’s Change
16.60
Today|||52-Week Range
21.23
-3.80%
Year-to-Date

Today’s Trading

Previous close19.53
Today’s open19.68
Day’s range19.47 - 19.75
Volume245,065
Average volume (3 months)244,098
Market cap$830.1M
Dividend yield4.05%
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+2.41%
Earnings growth (this year)+4.54%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+3.18%
P/E ratio23.3
Price/Sales3.69
Price/Book4.98

Competitors

 Today’s
change
Today’s
% change
GHDXGenomic Health Inc+0.72+2.79%
AMAGAMAG Pharmaceuticals...-0.04-0.19%
AAAPAdvanced Accelerator...+0.47+1.92%
ALRPRBAlere Inc+0.05+0.01%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$194.8M
Annual profit (last year)$35.5M
Net profit margin18.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John A. Kraeutler
EVP-Operations &
Information Systems
Lawrence J. Baldini
Corporate headquarters
Cincinnati, Ohio

Forecasts

Partner Offers